Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

13 results
Display

Effect of dyslipidemia on vascular smooth muscle cell proliferation in a porcine coronary restenosis model

Jeong KJ, Kang P, Lee HY, Son HC, Park SH, Choi WS, Koo BS, Jeon CY, Baek SH, An YJ, Kim HK, Kim SS, Park JK, Bae IH, Park DS, Shim JW, Kim JU, Kim NY, Kim SU, Lim KS, Jeong MH

This study aimed to examine the effect of a mild elevation in serum cholesterol level in a porcine coronary overstretch restenosis model using a balloon angioplasty catheter or drug-eluting coronary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug- and Gene-eluting Stents for Preventing Coronary Restenosis

Lekshmi KM, Che HL, Cho CS, Park IK

Coronary artery disease (CAD) has been reported to be a major cause of death worldwide. Current treatment methods include atherectomy, coronary angioplasty (as a percutaneous coronary intervention), and coronary artery...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model

Bae IH, Jeong MH, Kim JH, Park YH, Lim KS, Park DS, Shim JW, Kim JH, Ahn Y, Hong YJ, Sim DS

BACKGROUND AND OBJECTIVES: Hyaluronic acid (HA) is highly biocompatible with cells and the extracellular matrix. In contrast to degradation products of a synthetic polymer, degradation products of HA do not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Stents Coated with Artemisinin or Dihydroartemisinin in a Porcine Coronary Restenosis Model

Jang S, Jeong MH, Lim KS, Bae IH, Park JK, Park DS, Shim JW, Kim JH, Kim HK, Sim DS, Hong YJ, Ahn Y, Kang JC

BACKGROUND AND OBJECTIVES: Artemisinin and dihydroartemisinin are drugs used to treat malaria. These drugs suppress inflammatory reactions. The aim of this study was to examine the anti-intima hyperplasia effect of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Pretreatment of Ezetimibe/Simvastatin on Arterial Healing and Endothelialization after Drug-Eluting Stent Implantation in a Porcine Coronary Restenosis Model

Sim DS, Jeong MH, Park DS, Kim JH, Lim KS, Kim HK, Kim SS, Cho JY, Jeong HC, Park KH, Hong YJ, Kim JH, Ahn Y, Cho JG, Park JC

BACKGROUND AND OBJECTIVES: We sought to evaluate the effect of the early use of ezetimibe/simvastatin (Vytorin(R)) on arterial healing and endothelialization after the implantation of a drug-eluting stent (DES) in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Histopathological Comparison among Biolimus, Zotarolimus and Everolimus-Eluting Stents in Porcine Coronary Restenosis Model

Lim KS, Jeong MH, Bae IH, Park DS, Kim JM, Kim JH, Cho DL, Sim DS, Park KH, Hong YJ, Ahn Y

BACKGROUND AND OBJECTIVES: The aim of this study was to examine the histolopathogical effects among the biolimus, zotarolimus, and everolimus eluting stent (EES) in the porcine coronary restenosis model. SUBJECTS AND...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Predictors of Coronary Restenosis after Drug-Eluting Stent Implantation in Diabetic and Nondiabetic Patients

Hong SJ, Kim MH, Ahn TH, Shim WJ, Park SM, Choi JI, Joo HJ, Shin SY, Lim SY, Lim DS

BACKGROUND AND OBJECTIVES: Coronary restenosis after drug-eluting stent (DES) implantation occurs more frequently in diabetic patients than in nondiabetic patients. We compared the parameters influencing the like-lihood of restenosis after...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coronary Restenosis after Drug-Eluting Stent Implantation in Diabetic Patients

Lim DS

In the era of drug-eluting stents (DESs), the angiographic rates of restenosis at later months have been dramatically reduced, but these rates have been less prominently reduced in diabetic patients....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Cobalt Alloy and Stainless Steel Core(r) Stent in a Porcine Coronary Restenosis Model

Kim JY, Yoon J, Jung IH, Wang HS, Ahn MS, Lee KH, Yoo BS, Lee SH, Choe KH, Jang Y, Ahn JM, Ryu YS

BACKGROUND AND OBJECTIVES: The stent material and thickness may influence the rate of restenosis following coronary artery stenting. A thin strut cobalt-alloy stent has been developed in an attempt to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Detection of Coronary Restenosis by Serial Doppler Echocardiographic Assessment of Coronary Flow Velocity Reserve after Percutaneous Intervention

Park JH, Kang DH, Lee SW, Lee EJ, Kang SJ, Song JM, Hong MK, Song JK, Park SW, Park SJ

BACKGROUND: A measurement of the coronary flow velocity reserve (CFVR) with transthoracic Doppler echocardiography (TDE) is a good noninvasive method for detecting a coronary stenosis. However, microcirculatory impairment is a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Relationship of Infection and Inflammation with Coronary Restenosis after Percutaneous Coronary Interventions

Joo SB, Jeong MH, Jeong WK, Park OY, Lee SR, Kim W, Kim KH, Kim KH, Yum JH, Rhew JY, Kim NH, Ahn YK, Shin JH, Cho JG, Park JC, Kang JC

BACKGROUND AND OBJECTIVES: Possible correlations between the serologic status concerning Cytomegalovirus(CMV), Chlamydia pneumoniae (CP), Helicobacter pylori(HP), their related markers of C-reactive protein(CRP), erythrocyte sedimentation rate(ESR), and the restenosis(RS) in patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Local Radiation using Ho-166 Balloon on Porcine Coronary Restenosis

Lee SW

BACKGROUND: Restenosis remains one of major clinical problems in the coronary intervention. The effects of local radiation using radioactive balloon loaded with Ho-166 on coronary restenosis in the porcine model...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coronary Restenosis - New Concept of Restenosis and New Targeted Therapy -

Chung WS, Hong SJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr